|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 88, 143-145, Copyright © 1985 by American College of Chest Physicians
ARTICLES |
CG Standertskjold-Nordenstam, JC Wandtke, WB Hood Jr, FT Zugibe and L Butler
Two asymptomatic patients from a group of 30 being treated with the antiarrhythmic drug amiodarone developed roentgenographic pulmonary and pleural reactions. Computed tomography in one patient with an uncommon radiographic pattern of fuzzy nodules showed the spatial distribution of the parenchymal changes, as well as unrecognized pleural thickening. The disease in these asymptomatic patients was presumably detected on the periodic chest roentgenogram at an early stage because the changes disappeared after withdrawal of the drug. Periodic chest radiographs are recommended during amiodarone therapy and CT may be useful in evaluation of patients with unusual chest radiographic findings.
This article has been cited by other articles:
![]() |
L. W. Poll, P. May, J.-A. Koch, G. Hetzel, P. Heering, and U. Modder HRCT Findings of Amiodarone Pulmonary Toxicity: Clinical and Radiologic Regression Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2001; 6(3): 307 - 311. [Abstract] [PDF] |
||||
![]() |
S. Y. Morelock and S. A. Sahn Drugs and the Pleura Chest, July 1, 1999; 116(1): 212 - 221. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |